• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

筛查的危害:一种分类法及其在肺癌筛查中的应用。

The harms of screening: a proposed taxonomy and application to lung cancer screening.

机构信息

Research Center for Excellence in Clinical Preventive Services, Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill2Department of Medicine, School of Medicine, University of North Carolina at Chapel Hill.

Research Center for Excellence in Clinical Preventive Services, Cecil G. Sheps Center for Health Services Research, University of North Carolina at Chapel Hill.

出版信息

JAMA Intern Med. 2014 Feb 1;174(2):281-5. doi: 10.1001/jamainternmed.2013.12745.

DOI:10.1001/jamainternmed.2013.12745
PMID:24322781
Abstract

IMPORTANCE

Making rational decisions about screening requires information about its harms, but high-quality evidence is often either not available or not used. One reason may be that we lack a coherent framework, a taxonomy, for conceptualizing and studying these harms.

OBJECTIVE

To create a taxonomy, we categorized harms from several sources: systematic reviews of screening, other published literature, and informal discussions with clinicians and patients. We used this information to develop an initial taxonomy and vetted it with local and national experts, making revisions as needed.

RESULTS

We propose a taxonomy with 4 domains of harm from screening: physical effects, psychological effects, financial strain, and opportunity costs. Harms can occur at any step of the screening cascade. We provide definitions for each harm domain and illustrate the taxonomy using the example of screening for lung cancer.

CONCLUSIONS AND RELEVANCE

The taxonomy provides a systematic way to conceptualize harms as experienced by patients. As shown in the lung cancer screening example, the taxonomy also makes clear where (which domains of harms and which parts of the screening cascade) we have useful information and where there are gaps in our knowledge. The taxonomy needs further testing and validation across a broad range of screening programs. We hope that further development of this taxonomy can improve our thinking about the harms of screening, thus informing our research, policy making, and decision making with patients about the wisdom of screening.

摘要

重要性

要想对筛查做出合理决策,就必须了解其危害,但高质量的证据往往不是没有,就是没有被采用。原因之一可能是我们缺乏一个连贯的框架,即一个分类学,来对这些危害进行概念化和研究。

目的

为了创建一个分类学,我们从几个来源对危害进行了分类:筛查的系统评价、其他已发表的文献以及与临床医生和患者的非正式讨论。我们利用这些信息开发了一个初始分类学,并与当地和全国的专家进行了核实,根据需要进行了修订。

结果

我们提出了一个包含 4 个筛查危害领域的分类学:身体影响、心理影响、经济压力和机会成本。危害可能发生在筛查级联的任何一个步骤。我们为每个危害领域提供了定义,并通过肺癌筛查的例子来说明分类学。

结论和相关性

该分类学为从患者角度对危害进行概念化提供了一种系统的方法。如肺癌筛查示例所示,该分类学还明确了我们有哪些有用的信息(哪些危害领域和筛查级联的哪些部分),以及我们的知识存在哪些空白。该分类学需要在广泛的筛查项目中进一步测试和验证。我们希望进一步开发这个分类学可以改进我们对筛查危害的思考,从而为我们的研究、政策制定以及与患者就筛查的明智性进行决策提供信息。

相似文献

1
The harms of screening: a proposed taxonomy and application to lung cancer screening.筛查的危害:一种分类法及其在肺癌筛查中的应用。
JAMA Intern Med. 2014 Feb 1;174(2):281-5. doi: 10.1001/jamainternmed.2013.12745.
2
Assessment of Lung Cancer Screening Program Websites.肺癌筛查计划网站评估。
JAMA Intern Med. 2020 Jun 1;180(6):824-830. doi: 10.1001/jamainternmed.2020.0111.
3
Cancer screening--benefits, harms and making an informed choice.癌症筛查——益处、危害与做出明智选择。
Aust Fam Physician. 2006 Jan-Feb;35(1-2):39-42.
4
Prostate cancer screening decisions: results from the National Survey of Medical Decisions (DECISIONS study).前列腺癌筛查决策:全国医疗决策调查(DECISIONS研究)结果
Arch Intern Med. 2009 Sep 28;169(17):1611-8. doi: 10.1001/archinternmed.2009.262.
5
[Balancing benefits and harms of population-based interventions, using the example of cancer screening].[以癌症筛查为例,权衡基于人群的干预措施的利弊]
Z Evid Fortbild Qual Gesundhwes. 2011;105(3):176-82. doi: 10.1016/j.zefq.2011.03.004. Epub 2011 Mar 26.
6
Communicating the balance sheet in breast cancer screening.乳腺癌筛查中的资产负债表沟通。
J Med Screen. 2012;19 Suppl 1:67-71. doi: 10.1258/jms.2012.012084.
7
When Is a Harm a Harm? Discordance between Patient and Medical Experts' Evaluation of Lung Cancer Screening Attributes.何时是伤害?肺癌筛查属性的患者与医学专家评估之间的差异。
Med Decis Making. 2021 Apr;41(3):317-328. doi: 10.1177/0272989X20987221. Epub 2021 Feb 6.
8
The role of communication in breast cancer screening: a qualitative study with Australian experts.沟通在乳腺癌筛查中的作用:一项对澳大利亚专家的定性研究。
BMC Cancer. 2015 Oct 19;15:741. doi: 10.1186/s12885-015-1749-0.
9
American Cancer Society guideline for the early detection of prostate cancer: update 2010.美国癌症协会前列腺癌早期检测指南:2010 年更新版。
CA Cancer J Clin. 2010 Mar-Apr;60(2):70-98. doi: 10.3322/caac.20066. Epub 2010 Mar 3.
10
Real-world evidence about potential psychosocial harms of lung cancer screening.关于肺癌筛查潜在心理社会危害的真实世界证据。
JAMA Intern Med. 2014 Aug;174(8):1416. doi: 10.1001/jamainternmed.2014.1643.

引用本文的文献

1
Physical harms in colorectal cancer screening: An overview of the reporting in systematic reviews and randomised controlled trials.结直肠癌筛查中的身体伤害:系统评价和随机对照试验报告综述
PLoS One. 2025 Sep 11;20(9):e0331104. doi: 10.1371/journal.pone.0331104. eCollection 2025.
2
Value of HCC surveillance in a landscape of emerging surveillance options: Perspectives of a multi-stakeholder modified Delphi panel.新兴监测选项背景下肝癌监测的价值:多利益相关方改良德尔菲小组的观点
Hepatology. 2025 Sep 1;82(3):794-809. doi: 10.1097/HEP.0000000000001203. Epub 2024 Dec 18.
3
Coronary atherosclerosis screening in asymptomatic adults using coronary artery calcium for cardiovascular prevention: a systematic review of randomised controlled trials and prospective cohorts.
使用冠状动脉钙化对无症状成年人进行冠状动脉粥样硬化筛查以预防心血管疾病:随机对照试验和前瞻性队列的系统评价
BMJ Open. 2025 Jul 5;15(7):e101472. doi: 10.1136/bmjopen-2025-101472.
4
Patients' experiences of, and psychological responses to, surveillance for pulmonary nodules detected through lung cancer screening.肺癌筛查中发现的肺结节监测患者的经历及心理反应。
BMJ Open Respir Res. 2025 Jun 12;12(1):e002498. doi: 10.1136/bmjresp-2024-002498.
5
Individual- and Group-Level Disparities Between Racial and Ethnic Groups in Lung Cancer Screening Eligibility Criteria.肺癌筛查资格标准中种族和族裔群体在个体及群体层面的差异。
JAMA Netw Open. 2025 Mar 3;8(3):e252172. doi: 10.1001/jamanetworkopen.2025.2172.
6
Stakeholders' perceptions and experiences of factors influencing the commissioning, delivery, and uptake of general health checks: a qualitative evidence synthesis.利益相关者对影响一般健康检查的委托、提供和接受因素的看法与体验:一项定性证据综合分析
Cochrane Database Syst Rev. 2025 Mar 20;3(3):CD014796. doi: 10.1002/14651858.CD014796.pub2.
7
Persisting challenges in the early detection of hepatocellular carcinoma.肝细胞癌早期检测中持续存在的挑战。
Expert Rev Anticancer Ther. 2025 Feb 24:1-12. doi: 10.1080/14737140.2025.2467184.
8
Do health professionals know about overdiagnosis in screening, and how are they dealing with it? A mixed-methods systematic scoping review.卫生专业人员是否了解筛查中的过度诊断,以及他们如何应对?一项混合方法的系统综述。
PLoS One. 2025 Feb 3;20(2):e0315247. doi: 10.1371/journal.pone.0315247. eCollection 2025.
9
Protocol for a systematic review and individual participant data meta-analysis for risk factors for lung cancer in individuals with lung nodules identified by low-dose CT screening.低剂量CT筛查发现的肺结节患者肺癌危险因素的系统评价和个体参与者数据荟萃分析方案
BMJ Open. 2025 Jan 25;15(1):e085118. doi: 10.1136/bmjopen-2024-085118.
10
Ethical Dimensions of Population-Based Lung Cancer Screening in Canada: Key Informant Qualitative Description Study.加拿大基于人群的肺癌筛查的伦理维度:关键信息提供者定性描述研究
Public Health Ethics. 2024 Aug 29;17(3):139-153. doi: 10.1093/phe/phae008. eCollection 2024 Nov.